Brilinta Market: Overview
The increasing rates of heart attacks and strokes has highly increased the popularity of Brilinta in the medical industry. According to the World Health Organization, approximately 17 million people die of cardiovascular diseases every year. This alarming number calls for a need to deploy a robust preventive measure. Moreover, brilinta also eliminates the risk of infection-related death. A study called Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor (XANTHIPPE) displayed considerable improvement in the lung function of the pneumonia patients using brilinta.
The rising popularity of brilinta among the physicians and patients has encouraged Transparency Market Research to conduct an in-depth research on the global brilinta market. In its latest study, TMR offers a comprehensive analysis of the market’s structure and shed light on the key growth dynamics. It highlights the growth scenario and competitive landscape of the market. Moreover, it states business strategies deployed by the key enterprises functioning in the global brilinta market and ascertains the challenges faced by them in the long run.
Get a Glimpse of the In-depth Analysis through Our Brilinta Market Report Brochure
Brilinta Market: Notable Developments and Competitive Analysis
There are a very few players operating in the global brilinta market as the drug was approved a few years back. Listed below are a few notable developments in the market:
In June 2015, Sun Pharmaceutical Industries Ltd. collaborated with AstraZeneca Pharma India Limited (AZPIL), a leading manufacturer of brilinta. The agreement was aimed at enhancing the distribution network of “Axcer”, a new brand of ticagrelor drug. AZPIL already markets a ticagrelor drug under the trademark “Brilinta” in India. This collaboration helped Sun Pharmaceutical Industries to build a robust brand image by promoting the use of ticagrelor in India.
Brilinta Market: Key Drivers and Restraints
In recent times, there has been a steady rise in the development of ticagrelor drugs due to rising FDA approvals. Moreover, it has a greater efficacy as compared clopidogrel in the treatment of acute coronary syndrome. The results of the PLAT trial showed that patients treated with ticagrelor were less likely to die from stroke, vascular causes, and heart attack. These factors have highly contributed to expansion of the global brilinta market.
However, despite the numerous driving factors, there are a few restraints that may restrict the market’s growth. Side effects associated with ticagrelor use such as bleeding and dyspnea may discourage the use of ticagrelor. Nonetheless, development of new phararmaceutical compounds containing ticagrelor and rising awareness pertaining to the benefits of brilinta may propel the global brilinta market’s expansion.
Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom Brilinta Market Report
Brilinta Market: Regional Analysis
Based on geography, the brilinta market is market is segmented into North America, Europe, China, and Japan. Out of these, North America is anticipated to dominate the global brilinta market due to increase in expenditure on healthcare facilities and rising geriatric population. The U.S. holds a major share in the market’s growth in this region due to rising cases of cardiovascular disorders. The market in Europe is also anticipated to grow at a promising pace due to rising patient population and recent progression in the economy. Furthermore, introduction of advanced treatment options and government initiatives have contributed to the brilinta market’s growth in this region. The market in China and Japan is anticipated to grow at a steady pace due to rising concerns regarding cardiovascular diseases and increasing research pertaining to the development of new drugs.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.